已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Skeletal Retention of Bisphosphonate (Pamidronate) and Its Relation to the Rate of Bone Resorption in Patients With Breast Cancer and Bone Metastases

医学 双膦酸盐 骨吸收 乳腺癌 N-末端末端肽 泌尿科 内科学 骨病 吸收 骨重建 癌症 骨质疏松症 内分泌学 碱性磷酸酶 骨钙素 化学 酶 生物化学
作者
Serge C.L.M. Cremers,Socrates E. Papapoulos,Hans A. J. Gelderblom,Caroline Seynaeve,Jan den Hartigh,Pieter Vermeij,Carin C.D. van der Rijt,Lia van Zuylen
出处
期刊:Journal of Bone and Mineral Research [Oxford University Press]
卷期号:20 (9): 1543-1547 被引量:56
标识
DOI:10.1359/jbmr.050522
摘要

UNLABELLED: Bisphosphonate pharmacokinetics may affect individual responses. Skeletal retention of pamidronate infused monthly to patients with bone metastases was highly variable (12-98%) and did not diminish with time, showing the capacity of the skeleton to retain large amounts of bisphosphonate. Relationships between skeletal retention of pamidronate and rate of bone resorption are complex and depend on previous treatment and the total amount of retained bisphosphonate. INTRODUCTION: Bisphosphonates (BPs) given intravenously every 3-4 weeks are effective in the management of metastatic bone disease from breast cancer, but responses among patients vary, and it is not known whether current dose and dose intervals are appropriate for an individual patient. An influence of pharmacokinetics of BPs on antiresorptive action may contribute to this variation in response. To test this hypothesis, we determined the skeletal retention of intravenous pamidronate and its association to the rate of bone resorption in patients with bone metastases from breast cancer. MATERIALS AND METHODS: In a cross-sectional study, 24-h urinary excretion of pamidronate and the biochemical marker of bone resorption N-terminal telopeptide of type 1 collagen and serum alkaline phosphatase were measured in 40 patients with bone metastases from breast cancer at the beginning, after 3-6 months, and after 1 year of treatment with intravenous pamidronate 90 mg every 3-4 weeks. RESULTS AND CONCLUSIONS: Skeletal retention (dose--amount excreted into urine) 2 days after infusion varied between 12% and 98% (mean, 62%) of the administered dose, but there were no differences in retention between patients receiving pamidronate for the first time or after 3-6 months or after 1 year of treatment. Retention of pamidronate was related to the prevalent rate of bone turnover in previously untreated patients, whereas no such relationship was found in previously treated patients. Rate of bone resorption after treatment seemed to be related to the amount of pamidronate retained. During 1 year of treatment, retention of pamidronate remained constant, indicating no saturation of skeletal binding sites with treatment. The variability in retention among individual patients can be attributed to the number of available binding sites. This is related, however, to bone turnover only before the start of treatment. The apparent relationships between skeletal retention and antiresorptive effect could have implications for the design of optimal therapeutic regimens with BPs in patients with bone metastases from breast cancer.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
可耐的花生完成签到,获得积分10
2秒前
单身的涫完成签到,获得积分10
5秒前
阿卡波糖拌饭完成签到 ,获得积分10
6秒前
呆萌绿海完成签到,获得积分20
6秒前
鲸落完成签到,获得积分10
7秒前
prof.zhang发布了新的文献求助10
7秒前
Zlj发布了新的文献求助30
8秒前
u806968发布了新的文献求助60
11秒前
拼搏的寒凝完成签到 ,获得积分10
13秒前
111发布了新的文献求助10
13秒前
yu完成签到 ,获得积分0
15秒前
bkagyin的应助被正直立果采纳,获得10
15秒前
17秒前
3921337477的应助被u682286采纳,获得60
18秒前
mix完成签到 ,获得积分0
19秒前
21秒前
21秒前
呼延水云完成签到,获得积分10
21秒前
Karma完成签到,获得积分10
22秒前
moriaty发布了新的文献求助20
23秒前
prof.zhang完成签到,获得积分10
24秒前
wang完成签到 ,获得积分10
25秒前
26秒前
Maestro_S的应助被漂亮的大碗采纳,获得10
26秒前
完美亦竹完成签到 ,获得积分10
27秒前
kali发布了新的文献求助10
28秒前
u682286发布了新的文献求助60
31秒前
阿四发布了新的文献求助10
31秒前
常川禹完成签到,获得积分10
33秒前
大兔米菲完成签到 ,获得积分10
33秒前
33秒前
传统的开山完成签到,获得积分10
34秒前
幸福一江完成签到,获得积分10
38秒前
Zngas发布了新的文献求助10
38秒前
Orange的应助被kali采纳,获得10
38秒前
小喵不上课完成签到 ,获得积分10
38秒前
思源的应助被benbenca采纳,获得10
41秒前
orixero的应助被benbenca采纳,获得10
42秒前
42秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184932
求助须知:如何正确求助?哪些是违规求助? 9573843
关于积分的说明 21833435
捐赠科研通 7782323
什么是DOI,文献DOI怎么找? 3434429
关于科研通互助平台的介绍 2558632
邀请新用户注册赠送积分活动 2481161